For inquiries regarding the utilization of ethnobotanicals, or in case you are experiencing an adverse situation or difficulty integrating and experience, please read this page. For inquiries regarding legal support , please read this page.
On February 11, 2025, ICEERS organized a webinar entitled “Testimonies of legal cases around ayahuasca.” The event brought together people who have faced legal proceedings for ayahuasca use and members of ICEERS’ legal and scientific team, who provided them with support through the Ayahuasca Defense Fund (ADF).
Numerous international experts and organizations have come to Barcelona to study the CSC model and explore ways to implement it in their own regions. In
A new ICEERS report estimates the number of people drinking ayahuasca worldwide and analyzes fatalities reported by the media.
Spain has a decades long context for ayahuasca ceremonial practices. Despite a reported low prevalence of ayahuasca consumption, our investigation highlights the distinctive characteristics of Spanish ayahuasca drinkers.
Ayahuasca consumption in the United States in 2019, according to the report Ayahuasca, Global Consumption & Reported Deaths in the Media.
How many ayahuasca retreat centers operate in the Amazon? And how many people visit them? This research led us to estimate that there were at least 232 retreat centers operating in Amazonian countries and Costa Rica in 2019.
The mainstream media seemed to have it pinpointed: ayahuasca was the cause of these 58 fatalities. And ayahuasca’s mention in the headline offered undeniable clickbait from a journalistic point of view.
If the ayahuasqueros of the world united, they could create a human chain stretching from Madrid to Moscow and back. This interesting tidbit is based on recent research from ICEERS that reveals that approximately four million people have taken ayahuasca at some time in their lives in America, Europe, Australia, and New Zealand.
A new ICEERS report estimates the number of people drinking ayahuasca worldwide and analyzes fatalities reported by the media.
In the final installment of our interview series with David Londoño, psychologist and coordinator of the ICEERS Support Center, we explore difficult experiences with ayahuasca.
An acquittal was given in Mexico City in the trial of Don Jose Campos, a 64-year-old indigenous healer from the Peruvian Amazon who was arrested and imprisoned in March of 2022 for traveling with ayahuasca.
“Ayahuasca told me…” is a phrase often heard in integration circles, where people literally interpret messages as being “from the plant” as opposed to via their own internal world. David, ICEERS Support Center Coordinator, shares further insight.
Mexico is facing a historic opportunity to reverse past situations that have colonized the legal system by classifying mushrooms as prohibited substances due to the implications of international drug control treaties, despite their longstanding cultural and traditional significance safeguarded by Mexican Indigenous peoples.
ICEERS and colleagues have published a new paper offering the most detailed report thus far on the topic, Adverse Effects of Ayahuasca: Results from the Global Ayahuasca Survey, in the open-access journal PLOS Global Public Health.
ICEERS supports the development of evidence-informed policies and is committed to advancing clinical research. To support the collective knowledge on these topics, our organization launched the first-ever Phase II clinical trial in 2020 examining the efficacy of ibogaine for opioid dependence and detox from methadone.
This article, which is Part 1 in a series outlining ideas and perspectives from the Support Centre, is an interview with David where he speaks in depth about the complexity of ego dissolution as related to master plant experiences.
The new fundraising and education platform Grow Medicine provides people interested in iboga, ayahuasca, toad, peyote, and mushrooms the opportunity to learn more about conservation issues and to donate to support Indigenous-led initiatives.
When it comes to integration therapy, Marc Aixalà has witnessed a vast evolution being shaped by the increasing interest in psychedelics. He was the first person to field people’s requests for guidance when the ICEERS Integration and Support Centre opened in 2013. He then volunteered to assist people having challenging psychedelic experiences at festivals in Europe.
Ibogaine activist and entrepreneur, Robert Rand (also known as Bob Sisko) was one of the pioneers of the early ibogaine movement in the 1970s. He recently passed away at the age of 75 after a battle with liver cancer. To honor his memory, ICEERS spoke with his son Noah Rand and important figures who knew Sisko during different stages of life.
A new report Coca Leaf in Court: Cultural Rights and the Toxicological Labyrinth published by Constanza Sánchez, Dr. José Carlos Bouso, Pien Metaal, and Roberto Castro highlights the concerns with how coca cases are addressed in Spain, and the precedence this sets in other parts of the world.
Psychoactive plants and fungi are becoming more well-known, and we are beginning to hear more about amphibians whose secretions are also able to alter consciousness. The toad known as “Bufo” is increasingly being talked about in the media and online forums. The Latin nomenclature of Bufo alvarius is often used to refer to a species of toad that produces large quantities of the psychoactive substance 5-MeO-DMT within its specialized skin glands, most prominently, its parotid glands. But this infamous amphibian goes by many other names, scientific or otherwise, which we will get into more detail about here.
According to a newly released study published in the Journal of Psychoactive Drugs, ayahuasca may help support a healthy lifestyle. The long-term impact investigation was carried out by the Research team at ICEERS, in collaboration with the Autonomous University of Madrid, University Rovira i Virgili, University of São Paulo, and Leiden University. The study assessed 377 participants taking part in ayahuasca ceremonies in the Netherlands.
In March 2022, Italy’s government made the two principal ingredients of ayahuasca Schedule I controlled substances. Read our comments here.
ICEERS started the first ever Phase II clinical trial exploring the potential of ibogaine to treat opioid dependency. Click here to learn more.
